Log in to save to my catalogue

AB0622 LUPUS NEPHRITIS: IS THE KIDNEY BIOPSY CURRENTLY NECESSARY IN THE MANAGEMENT OF LUPUS NEPHRITI...

AB0622 LUPUS NEPHRITIS: IS THE KIDNEY BIOPSY CURRENTLY NECESSARY IN THE MANAGEMENT OF LUPUS NEPHRITI...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2825269137

AB0622 LUPUS NEPHRITIS: IS THE KIDNEY BIOPSY CURRENTLY NECESSARY IN THE MANAGEMENT OF LUPUS NEPHRITIS?

About this item

Full title

AB0622 LUPUS NEPHRITIS: IS THE KIDNEY BIOPSY CURRENTLY NECESSARY IN THE MANAGEMENT OF LUPUS NEPHRITIS?

Publisher

Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1513-1513

Language

English

Formats

Publication information

Publisher

Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

BackgroundLupus Nephritis (LN) is an immune-complex mediated glomerulonephritis affecting up to 60% of all SLE patients during the disease course. A kidney biopsy is indicated in SLE patients when proteinuria stably reaches or overcomes the level of 500 mg/24 h or spot urine protein to creatinine ratio (UPCR) >500 mg/g (50 mg/mmol), especially with...

Alternative Titles

Full title

AB0622 LUPUS NEPHRITIS: IS THE KIDNEY BIOPSY CURRENTLY NECESSARY IN THE MANAGEMENT OF LUPUS NEPHRITIS?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2825269137

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2825269137

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2023-eular.1134

How to access this item